Design and synthesis of phenethyl benzo[1,4]oxazine-3-ones as potent inhibitors of PI3Kinaseγ

被引:42
作者
Lanni, Thomas B., Jr.
Greene, Keri L.
Kolz, Christine N.
Para, Kimberly S.
Visnick, Melean
Mobley, James L.
Dudley, David T.
Baginski, Theodore J.
Liimatta, Marya B.
机构
[1] Pfizer Global Res & Dev, Dept Chem, Ann Arbor, MI 48105 USA
[2] Pfizer Global Res & Dev, Dept Pharmacol, Ann Arbor, MI 48105 USA
关键词
PI3Kinase; phosphomositide; 3-kinase; rheumatoid arthritis; peritonitis; inflammatory; Granulocytes; monocytes; intracellular; PI3K-gamma; inhibitor;
D O I
10.1016/j.bmcl.2006.10.080
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The Type 1 PI3Kinases comprise a family of enzymes, which primarily phosphorylate PIP2 to give the second messenger PIP3, a key player in many intracellular signaling processes [Science, 2002, 296, 1655; Trends Pharmacol. Sci. 2003, 24, 366]. Of the four type 1 PI3Ks, the gamma-isoform, which is expressed almost exclusively in leukocytes [Curr. Biol., 1997, 7, R470], is of particular interest with respect to its role in inflammatory diseases such as rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD) [Mol. Med. Today, 2000, 6, 347]. Investigation of a series of 4,6-disubstituted-4H-benzo[1,4]oxazin-3-ones has led to the identification of single-digit nanomolar inhibitors of PI3K gamma, several of which had good cell based activity and were shown to be active in vivo in an aspectic peritonitis model of inflammatory cell migration. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:756 / 760
页数:5
相关论文
共 15 条
[1]   Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase [J].
Bi, L ;
Okabe, I ;
Bernard, DJ ;
Wynshaw-Boris, A ;
Nussbaum, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10963-10968
[2]   Signalling enzymes: Bursting with potential [J].
Braselmann, S ;
Palmer, TM ;
Cook, SJ .
CURRENT BIOLOGY, 1997, 7 (08) :R470-R473
[3]   The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[4]   LY294002-geldanamycin heterodimers as selective inhibitors of the PI3K and PI3K-related family [J].
Chiosis, G ;
Rosen, N ;
Sepp-Lorenzino, L .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (07) :909-913
[5]   3-(2,5-dioxopyrrolidin-1-yl), 3-(2,6-dioxopiperidin-1-yl), and 3-(1,3-dioxoisoindolin-2-yl)rhodanines. A novel type of rhodanine derivatives [J].
Hanefeld, W ;
Schlitzer, M ;
Debski, N ;
Euler, H .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1996, 33 (04) :1143-1146
[6]   Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation [J].
Hirsch, E ;
Katanaev, VL ;
Garlanda, C ;
Azzolino, O ;
Pirola, L ;
Silengo, L ;
Sozzani, S ;
Mantovani, A ;
Altruda, F ;
Wymann, MP .
SCIENCE, 2000, 287 (5455) :1049-1053
[7]   Gβγ stimulates phosphoinositide 3-kinase-γ by direct interaction with two domains of the catalytic p110 subunit [J].
Leopoldt, D ;
Hanck, T ;
Exner, T ;
Maier, U ;
Wetzker, R ;
Nürnberg, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) :7024-7029
[8]   Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction [J].
Li, Z ;
Jiang, HP ;
Xie, W ;
Zhang, ZC ;
Smrcka, AV ;
Wu, DQ .
SCIENCE, 2000, 287 (5455) :1046-1049
[9]   2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution [J].
Ornstein, PL ;
Bleisch, TJ ;
Arnold, MB ;
Wright, RA ;
Johnson, BG ;
Schoepp, DD .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (03) :346-357
[10]   Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration [J].
Sasaki, T ;
Irie-Sasaki, J ;
Jones, RG ;
Oliveira-dos-Santos, AJ ;
Stanford, WL ;
Bolon, B ;
Wakeham, A ;
Itie, A ;
Bouchard, D ;
Kozieradzki, I ;
Joza, N ;
Mak, TW ;
Ohashi, PS ;
Suzuki, A ;
Penninger, JM .
SCIENCE, 2000, 287 (5455) :1040-1046